Mount Sinai and LifeMap Solutions announce initial results for asthma health app – Medical Xpress

Mount Sinai and LifeMap Solutions announce initial results for asthma health app
Medical Xpress
The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a digital-health subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced initial results and new clinical features for their free Asthma Health app. Released six months ago, the
Asthma app moves from research to realitymHealthNews
Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health Newswise (press release)

all 8 news articles »

View full post on asthma – Google News

Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health … – Newswise (press release)

Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health
Newswise (press release)
“We are delighted with the initial results we've seen after six months of using Apple's ResearchKit framework for our Asthma Health app,” said Eric Schadt, PhD, the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at

and more »

View full post on asthma – Google News

Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in … – Benzinga

Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in
Benzinga
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma, who are uncontrolled despite treatment with …

and more »

View full post on asthma – Google News

Reliable Cure for Asthma Discovered; Scientists Announce Breakthrough … – Yibada (English Edition)


Yibada (English Edition)

Reliable Cure for Asthma Discovered; Scientists Announce Breakthrough
Yibada (English Edition)
Medical experts said this unexpected breakthrough could pave the way for a new treatment for asthma within five years. That's because a drug already exists doctors think could deactivate this asthma-inducing protein called a "Calcium-sensing receptor

View full post on asthma – Google News

San Diego Doctors, California’s Nurses Announce Support of Propositions B & C – San Diego Free Press


San Diego Free Press

San Diego Doctors, California's Nurses Announce Support of Propositions B & C
San Diego Free Press
The attendees all agreed that the current, incompatible and polluting land-use policies in Barrio Logan must be changed to reverse the trend of unhealthy air causing high asthma rates among our kids. Barrio Logan has one of the highest asthma rates in

and more »

View full post on asthma – Google News

GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … – RTT News

GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma
RTT News
GlaxoSmithKline plc(GSK: Quote,GSK.L), and Theravance, Inc.(THRX: Quote), Friday said that Relvar Ellipta for the treatment of bronchial asthma got approval from the Japanese Ministry of Health, Labour and Welfare. The company said Relvar Ellipta is
Japan approves lung drugs from GSK/Theravance and SkyePharmaReuters
Glaxo's Relvar Lung Treatment Recommended by EU RegulatorBloomberg
GlaxoSmithKline Treatments Given Positive Opinion In Europe, Approved in JapanLondon South East

all 8 news articles »

View full post on asthma – Google News

CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data … – PR Newswire (press release)

CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data
PR Newswire (press release)
AUSTIN, Texas, Sept. 18, 2013 /PRNewswire/ — The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma Inc. ("TransCelerate"), are pleased to announce that version 1.0 of the Asthma Therapeutic Area (TA) Data Standard 

and more »

View full post on asthma – Google News

PPD and Global Allergy and Asthma European Network (GA2LEN) Announce … – The Herald | HeraldOnline.com

PPD and Global Allergy and Asthma European Network (GA2LEN) Announce
The Herald | HeraldOnline.com
WILMINGTON, N.C., & BERLIN, Germany — Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the

and more »

View full post on asthma – Google News

GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and … – MarketWatch (press release)

GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and
MarketWatch (press release)
Asthma (100/25mcg and 200/25mcg): The regular treatment of asthma in adults and adolescents aged 12 years and older, where use of a combination product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate. COPD (100/25mcg): The
GSK, Theravance unveil Regulatory Submissions for FF/VI in US, EuropeRTT News
GSK files key new lung drug for regulatory approvalWHTC

all 7 news articles »

View full post on asthma – Google News